Serological analysis notes 1-27-13
2015-01-13azim58 - Serological analysis notes 1-27-13
Concepts to cover
importance of antibodies
- present before symptoms occur
- persistence and stability of antibodies
- antibodies can be used therapeutically such as rituximab and herceptin
- associated with T cells (the development of high-titre IgG requires CD4
history before SEREX
- a few antigens at a time with 1D SDS/PAGE and ELISA
(a novel strategy using the antibody
repertoire of cancer patients for the molecular definition
of antigens was developed by Pfreundschuh and his
colleagues Sahin and Tu¨ reci 15)
advantages of serex
- can probe for intracellular antigens
- avoid artifacts of cultured cells
- SEREX, phage display, protein microarray, SERPA, ad MAPPing
- SEREX
- -limitations of serex
- ---linear epitopes (-good expression in bacteria, -antigens with the
abundance are missed by SEREX, -SEREX is time-consuming and
labour-intensive, -antibodies to non-tumor associated antigens)
- microarray
- -small sample amount, Proto-Array from Invitrogen with 80,000
SERPA
- -biased approach (with known analytes) (autoantibody or autoantigen)
- -unbiased approach (new analytes can be discovered) (phage display or
- -pro: high throughput and a lot of data, con: cost and a lot of data
- serological proteome analysis (2D electropheresis (of tumor lysate)->
- -fast, post-translational modifications
- -cons (limited material
issues with reproducibility)
SEREX database
(Cancer Immunome Database, contains all the autoantigens identified by
SEREX)
types of antigens identified (including intracellular antigens)
- cancer testis (CT) antigens
- aberrantly expressed antigens such as HER2/neu, p53, and ras
- oncoproteins ( HER-2 / Neu, ras and
- tumor suppressor proteins p53
- viral antigens
- cell differentiation antigens
- heat shock proteins (This is because HSPs play important roles in cancer
255–257)
^see list of proteins in document